p21 Antibody (YA3989)

p21 Antibody (YA3989) is a mouse-derived and non-conjugated IgG1 antibody, targeting to CDKN1A. It can be applicated for ICC/IF, FC, ELISA assays, in the background of human.

The CDKN1A protein assumes a crucial role in controlling cell cycle progression and orchestrating DNA damage-induced G2 arrest. It actively participates in p53/TP53-mediated inhibition of cellular proliferation in response to DNA damage and is also implicated in p53-independent DNA damage-induced G2 arrest, mediated by CREB3L1 in astrocytes and osteoblasts. Functionally, CDKN1A binds to and inhibits cyclin-dependent kinase activity, preventing the phosphorylation of critical cyclin-dependent kinase substrates and thereby blocking cell cycle progression. It contributes to the nuclear localization and assembly of the cyclin D-CDK4 complex, promoting its kinase activity towards RB1. At higher stoichiometric ratios, CDKN1A inhibits the kinase activity of the cyclin D-CDK4 complex and competes with POLD3 for PCNA binding, leading to the inhibition of DNA synthesis by DNA polymerase delta. The intricate regulatory network of CDKN1A includes interactions with HDAC1, MKRN1, PSMA3, CDK4, CDK2, PIM1, STK11, NUAK1, and TRIM39 isoforms, reflecting its diverse role in cell cycle regulation and DNA damage response.

P38936

Predicted band size: 18 kDa; Observed band size: 21 kDa

affinity purified.

Non-conjugated

Primary Antibody; Mouse Monoclonal Antibody

Mouse

Human

IF: 1/25-1/200; FC: 1/200-1/400; ELISA: 1/10000

ICC/IF, FC, ELISA

Liquid

Supplied in PBS with 0.05% sodium azide

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Shipping with blue ice.

IgG1

Purified recombinant fragment of human CDKN1A (AA: 1-164) expressed in E. Coli.